glp 1 masld Role of glucagon-like peptide-1 receptor agonists in pediatric obesity and metabolic dysfunction associated steatotic liver disease Beyond glucagon-like peptide-1: The promise
Description
The studys authors examined over 3,000 participants, none of whom had diabetes or were taking medication to lower their blood sugar

Serious Risks Rare but important: Pancreatitis: Occurs in a small percentage of patients
What are the potential side effects of GLP-1 agonists

European journal of preventive cardiology

Companies cant freely promote what a drug treats or promise results

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are pharmacological agents that mimic the hormone's endogenous activity
